nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0926	0.135	CbGbCtD
Procainamide—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0731	0.107	CbGbCtD
Procainamide—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.071	0.104	CbGbCtD
Procainamide—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0709	0.104	CbGbCtD
Procainamide—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0642	0.0938	CbGbCtD
Procainamide—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0548	0.0801	CbGbCtD
Procainamide—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0476	0.0696	CbGbCtD
Procainamide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0288	0.042	CbGbCtD
Procainamide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.027	0.0395	CbGbCtD
Procainamide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.027	0.0395	CbGbCtD
Procainamide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0245	0.0357	CbGbCtD
Procainamide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0245	0.0357	CbGbCtD
Procainamide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0211	0.0308	CbGbCtD
Procainamide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0205	0.0299	CbGbCtD
Procainamide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0185	0.0271	CbGbCtD
Procainamide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0185	0.0271	CbGbCtD
Procainamide—SCN11A—nerve—acquired immunodeficiency syndrome	0.00627	0.0623	CbGeAlD
Procainamide—SCN8A—nerve—acquired immunodeficiency syndrome	0.00475	0.0472	CbGeAlD
Procainamide—SCN10A—nerve—acquired immunodeficiency syndrome	0.00318	0.0316	CbGeAlD
Procainamide—SCN11A—digestive system—acquired immunodeficiency syndrome	0.00182	0.0181	CbGeAlD
Procainamide—DNMT1—retina—acquired immunodeficiency syndrome	0.0017	0.0168	CbGeAlD
Procainamide—SCN11A—spinal cord—acquired immunodeficiency syndrome	0.00167	0.0166	CbGeAlD
Procainamide—DNMT1—skin of body—acquired immunodeficiency syndrome	0.00149	0.0148	CbGeAlD
Procainamide—SCN11A—nervous system—acquired immunodeficiency syndrome	0.00141	0.014	CbGeAlD
Procainamide—SCN11A—central nervous system—acquired immunodeficiency syndrome	0.00136	0.0135	CbGeAlD
Procainamide—SCN7A—lung—acquired immunodeficiency syndrome	0.00129	0.0129	CbGeAlD
Procainamide—SCN8A—spinal cord—acquired immunodeficiency syndrome	0.00127	0.0126	CbGeAlD
Procainamide—BCHE—blood plasma—acquired immunodeficiency syndrome	0.00124	0.0123	CbGeAlD
Procainamide—DNMT1—lymphoid tissue—acquired immunodeficiency syndrome	0.00121	0.012	CbGeAlD
Procainamide—DNMT1—digestive system—acquired immunodeficiency syndrome	0.00119	0.0118	CbGeAlD
Procainamide—DNMT1—blood—acquired immunodeficiency syndrome	0.00113	0.0113	CbGeAlD
Procainamide—SCN9A—spinal cord—acquired immunodeficiency syndrome	0.00111	0.0111	CbGeAlD
Procainamide—DNMT1—bone marrow—acquired immunodeficiency syndrome	0.0011	0.0109	CbGeAlD
Procainamide—DNMT1—spinal cord—acquired immunodeficiency syndrome	0.00109	0.0109	CbGeAlD
Procainamide—SCN11A—brain—acquired immunodeficiency syndrome	0.00108	0.0107	CbGeAlD
Procainamide—SCN8A—nervous system—acquired immunodeficiency syndrome	0.00107	0.0106	CbGeAlD
Procainamide—DNMT1—vagina—acquired immunodeficiency syndrome	0.00105	0.0104	CbGeAlD
Procainamide—SCN8A—central nervous system—acquired immunodeficiency syndrome	0.00103	0.0102	CbGeAlD
Procainamide—SCN9A—lung—acquired immunodeficiency syndrome	0.00101	0.0101	CbGeAlD
Procainamide—DNMT1—lung—acquired immunodeficiency syndrome	0.000994	0.00988	CbGeAlD
Procainamide—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000994	0.00988	CbGeAlD
Procainamide—SCN1A—spinal cord—acquired immunodeficiency syndrome	0.000959	0.00952	CbGeAlD
Procainamide—SCN10A—lymphoid tissue—acquired immunodeficiency syndrome	0.000936	0.00929	CbGeAlD
Procainamide—DNMT1—nervous system—acquired immunodeficiency syndrome	0.000921	0.00915	CbGeAlD
Procainamide—SCN7A—brain—acquired immunodeficiency syndrome	0.000916	0.0091	CbGeAlD
Procainamide—SCN2A—blood—acquired immunodeficiency syndrome	0.000913	0.00907	CbGeAlD
Procainamide—ACHE—spinal cord—acquired immunodeficiency syndrome	0.000888	0.00882	CbGeAlD
Procainamide—DNMT1—central nervous system—acquired immunodeficiency syndrome	0.000887	0.0088	CbGeAlD
Procainamide—SCN7A—lymph node—acquired immunodeficiency syndrome	0.000885	0.00879	CbGeAlD
Procainamide—SCN10A—blood—acquired immunodeficiency syndrome	0.000881	0.00874	CbGeAlD
Procainamide—SCN2A—spinal cord—acquired immunodeficiency syndrome	0.00088	0.00874	CbGeAlD
Procainamide—SCN1A—lung—acquired immunodeficiency syndrome	0.000872	0.00866	CbGeAlD
Procainamide—SCN10A—spinal cord—acquired immunodeficiency syndrome	0.000848	0.00842	CbGeAlD
Procainamide—SCN2A—vagina—acquired immunodeficiency syndrome	0.000847	0.00841	CbGeAlD
Procainamide—SCN5A—digestive system—acquired immunodeficiency syndrome	0.00084	0.00834	CbGeAlD
Procainamide—SCN4A—nervous system—acquired immunodeficiency syndrome	0.000838	0.00832	CbGeAlD
Procainamide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000819	0.00813	CbGeAlD
Procainamide—SCN8A—brain—acquired immunodeficiency syndrome	0.000817	0.00811	CbGeAlD
Procainamide—SCN1A—nervous system—acquired immunodeficiency syndrome	0.000808	0.00802	CbGeAlD
Procainamide—SCN4A—central nervous system—acquired immunodeficiency syndrome	0.000806	0.00801	CbGeAlD
Procainamide—SCN3A—blood—acquired immunodeficiency syndrome	0.000803	0.00797	CbGeAlD
Procainamide—SCN5A—blood—acquired immunodeficiency syndrome	0.0008	0.00795	CbGeAlD
Procainamide—SCN1A—central nervous system—acquired immunodeficiency syndrome	0.000778	0.00772	CbGeAlD
Procainamide—SCN3A—bone marrow—acquired immunodeficiency syndrome	0.000777	0.00771	CbGeAlD
Procainamide—SCN3A—spinal cord—acquired immunodeficiency syndrome	0.000773	0.00768	CbGeAlD
Procainamide—SCN10A—lung—acquired immunodeficiency syndrome	0.000772	0.00767	CbGeAlD
Procainamide—SCN3A—vagina—acquired immunodeficiency syndrome	0.000744	0.00739	CbGeAlD
Procainamide—SCN5A—vagina—acquired immunodeficiency syndrome	0.000742	0.00737	CbGeAlD
Procainamide—SCN2A—nervous system—acquired immunodeficiency syndrome	0.000741	0.00736	CbGeAlD
Procainamide—SLC22A4—digestive system—acquired immunodeficiency syndrome	0.000738	0.00733	CbGeAlD
Procainamide—SCN9A—brain—acquired immunodeficiency syndrome	0.000718	0.00713	CbGeAlD
Procainamide—SCN10A—nervous system—acquired immunodeficiency syndrome	0.000715	0.0071	CbGeAlD
Procainamide—SCN2A—central nervous system—acquired immunodeficiency syndrome	0.000714	0.00709	CbGeAlD
Procainamide—DNMT1—brain—acquired immunodeficiency syndrome	0.000704	0.00699	CbGeAlD
Procainamide—SCN3A—lung—acquired immunodeficiency syndrome	0.000704	0.00699	CbGeAlD
Procainamide—SLC22A4—blood—acquired immunodeficiency syndrome	0.000703	0.00698	CbGeAlD
Procainamide—SLC22A5—retina—acquired immunodeficiency syndrome	0.000695	0.0069	CbGeAlD
Procainamide—SCN9A—lymph node—acquired immunodeficiency syndrome	0.000693	0.00689	CbGeAlD
Procainamide—SCN10A—central nervous system—acquired immunodeficiency syndrome	0.000688	0.00683	CbGeAlD
Procainamide—DNMT1—lymph node—acquired immunodeficiency syndrome	0.00068	0.00675	CbGeAlD
Procainamide—SLC22A4—bone marrow—acquired immunodeficiency syndrome	0.00068	0.00675	CbGeAlD
Procainamide—SLC22A4—spinal cord—acquired immunodeficiency syndrome	0.000677	0.00672	CbGeAlD
Procainamide—SLC22A1—blood—acquired immunodeficiency syndrome	0.000669	0.00665	CbGeAlD
Procainamide—SCN3A—nervous system—acquired immunodeficiency syndrome	0.000652	0.00647	CbGeAlD
Procainamide—SLC22A4—vagina—acquired immunodeficiency syndrome	0.000651	0.00647	CbGeAlD
Procainamide—SCN5A—nervous system—acquired immunodeficiency syndrome	0.00065	0.00645	CbGeAlD
Procainamide—SCN4A—brain—acquired immunodeficiency syndrome	0.00064	0.00636	CbGeAlD
Procainamide—SCN3A—central nervous system—acquired immunodeficiency syndrome	0.000627	0.00623	CbGeAlD
Procainamide—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.000625	0.00621	CbGeAlD
Procainamide—SLC22A1—vagina—acquired immunodeficiency syndrome	0.00062	0.00616	CbGeAlD
Procainamide—SCN1A—brain—acquired immunodeficiency syndrome	0.000617	0.00613	CbGeAlD
Procainamide—SLC22A4—lung—acquired immunodeficiency syndrome	0.000616	0.00612	CbGeAlD
Procainamide—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.00061	0.00606	CbGeAlD
Procainamide—BCHE—skin of body—acquired immunodeficiency syndrome	0.000594	0.0059	CbGeAlD
Procainamide—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000593	0.00589	CbGeAlD
Procainamide—ACHE—brain—acquired immunodeficiency syndrome	0.000572	0.00568	CbGeAlD
Procainamide—SCN2A—brain—acquired immunodeficiency syndrome	0.000567	0.00563	CbGeAlD
Procainamide—SLC22A3—lung—acquired immunodeficiency syndrome	0.000561	0.00557	CbGeAlD
Procainamide—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000553	0.00549	CbGeAlD
Procainamide—ACHE—lymph node—acquired immunodeficiency syndrome	0.000553	0.00549	CbGeAlD
Procainamide—SCN10A—brain—acquired immunodeficiency syndrome	0.000546	0.00543	CbGeAlD
Procainamide—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000543	0.00539	CbGeAlD
Procainamide—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000532	0.00529	CbGeAlD
Procainamide—SCN10A—lymph node—acquired immunodeficiency syndrome	0.000528	0.00524	CbGeAlD
Procainamide—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000523	0.00519	CbGeAlD
Procainamide—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000519	0.00516	CbGeAlD
Procainamide—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.0005	0.00496	CbGeAlD
Procainamide—SCN3A—brain—acquired immunodeficiency syndrome	0.000498	0.00495	CbGeAlD
Procainamide—SCN5A—brain—acquired immunodeficiency syndrome	0.000497	0.00493	CbGeAlD
Procainamide—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000488	0.00485	CbGeAlD
Procainamide—SCN3A—lymph node—acquired immunodeficiency syndrome	0.000481	0.00478	CbGeAlD
Procainamide—BCHE—digestive system—acquired immunodeficiency syndrome	0.000475	0.00472	CbGeAlD
Procainamide—SLC22A5—blood—acquired immunodeficiency syndrome	0.000465	0.00462	CbGeAlD
Procainamide—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000457	0.00213	CcSEcCtD
Procainamide—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000455	0.00212	CcSEcCtD
Procainamide—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.000455	0.00212	CcSEcCtD
Procainamide—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000453	0.00211	CcSEcCtD
Procainamide—BCHE—blood—acquired immunodeficiency syndrome	0.000453	0.0045	CbGeAlD
Procainamide—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000452	0.00211	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000451	0.0021	CcSEcCtD
Procainamide—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.000451	0.0021	CcSEcCtD
Procainamide—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000451	0.0021	CcSEcCtD
Procainamide—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000451	0.0021	CcSEcCtD
Procainamide—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000449	0.00209	CcSEcCtD
Procainamide—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000449	0.00209	CcSEcCtD
Procainamide—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000449	0.00209	CcSEcCtD
Procainamide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000449	0.00209	CcSEcCtD
Procainamide—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000448	0.00445	CbGeAlD
Procainamide—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000448	0.00209	CcSEcCtD
Procainamide—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000445	0.00208	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000444	0.00207	CcSEcCtD
Procainamide—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000443	0.00207	CcSEcCtD
Procainamide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000442	0.00206	CcSEcCtD
Procainamide—Malaise—Indinavir—acquired immunodeficiency syndrome	0.000442	0.00206	CcSEcCtD
Procainamide—BCHE—bone marrow—acquired immunodeficiency syndrome	0.000438	0.00435	CbGeAlD
Procainamide—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000437	0.00203	CcSEcCtD
Procainamide—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.000437	0.00203	CcSEcCtD
Procainamide—BCHE—spinal cord—acquired immunodeficiency syndrome	0.000436	0.00433	CbGeAlD
Procainamide—SLC22A4—brain—acquired immunodeficiency syndrome	0.000436	0.00433	CbGeAlD
Procainamide—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000434	0.00202	CcSEcCtD
Procainamide—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000434	0.00202	CcSEcCtD
Procainamide—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000431	0.00201	CcSEcCtD
Procainamide—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000431	0.00428	CbGeAlD
Procainamide—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.00043	0.002	CcSEcCtD
Procainamide—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.00043	0.002	CcSEcCtD
Procainamide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000428	0.00199	CcSEcCtD
Procainamide—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000424	0.00197	CcSEcCtD
Procainamide—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000423	0.00197	CcSEcCtD
Procainamide—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000423	0.00197	CcSEcCtD
Procainamide—CHRM2—brain—acquired immunodeficiency syndrome	0.000423	0.0042	CbGeAlD
Procainamide—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000422	0.00197	CcSEcCtD
Procainamide—Chills—Ritonavir—acquired immunodeficiency syndrome	0.000422	0.00197	CcSEcCtD
Procainamide—SLC22A4—lymph node—acquired immunodeficiency syndrome	0.000421	0.00418	CbGeAlD
Procainamide—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000421	0.00196	CcSEcCtD
Procainamide—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.00042	0.00196	CcSEcCtD
Procainamide—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00042	0.00196	CcSEcCtD
Procainamide—BCHE—vagina—acquired immunodeficiency syndrome	0.00042	0.00417	CbGeAlD
Procainamide—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000419	0.00195	CcSEcCtD
Procainamide—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000418	0.00195	CcSEcCtD
Procainamide—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000417	0.00194	CcSEcCtD
Procainamide—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000417	0.00194	CcSEcCtD
Procainamide—SLC22A1—brain—acquired immunodeficiency syndrome	0.000415	0.00412	CbGeAlD
Procainamide—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000412	0.00192	CcSEcCtD
Procainamide—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000411	0.00192	CcSEcCtD
Procainamide—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00041	0.00191	CcSEcCtD
Procainamide—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000409	0.00191	CcSEcCtD
Procainamide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000409	0.00191	CcSEcCtD
Procainamide—SLC22A5—lung—acquired immunodeficiency syndrome	0.000408	0.00405	CbGeAlD
Procainamide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000407	0.0019	CcSEcCtD
Procainamide—Chills—Saquinavir—acquired immunodeficiency syndrome	0.000406	0.00189	CcSEcCtD
Procainamide—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000406	0.00189	CcSEcCtD
Procainamide—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000405	0.00189	CcSEcCtD
Procainamide—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000405	0.00189	CcSEcCtD
Procainamide—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000405	0.00189	CcSEcCtD
Procainamide—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000405	0.00189	CcSEcCtD
Procainamide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000403	0.00188	CcSEcCtD
Procainamide—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000402	0.00187	CcSEcCtD
Procainamide—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000401	0.00187	CcSEcCtD
Procainamide—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000401	0.00187	CcSEcCtD
Procainamide—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000399	0.00186	CcSEcCtD
Procainamide—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000399	0.00186	CcSEcCtD
Procainamide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000397	0.00185	CcSEcCtD
Procainamide—BCHE—lung—acquired immunodeficiency syndrome	0.000397	0.00394	CbGeAlD
Procainamide—SLC22A3—brain—acquired immunodeficiency syndrome	0.000397	0.00394	CbGeAlD
Procainamide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000394	0.00184	CcSEcCtD
Procainamide—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000394	0.00184	CcSEcCtD
Procainamide—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000394	0.00184	CcSEcCtD
Procainamide—Shock—Indinavir—acquired immunodeficiency syndrome	0.000393	0.00183	CcSEcCtD
Procainamide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000393	0.00183	CcSEcCtD
Procainamide—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000392	0.00183	CcSEcCtD
Procainamide—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000392	0.00183	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000392	0.00183	CcSEcCtD
Procainamide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000392	0.00182	CcSEcCtD
Procainamide—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000391	0.00182	CcSEcCtD
Procainamide—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000391	0.00182	CcSEcCtD
Procainamide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00039	0.00182	CcSEcCtD
Procainamide—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000389	0.00181	CcSEcCtD
Procainamide—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000388	0.00181	CcSEcCtD
Procainamide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000387	0.0018	CcSEcCtD
Procainamide—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000386	0.0018	CcSEcCtD
Procainamide—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000385	0.0018	CcSEcCtD
Procainamide—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000385	0.0018	CcSEcCtD
Procainamide—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000383	0.00381	CbGeAlD
Procainamide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000381	0.00178	CcSEcCtD
Procainamide—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000381	0.00178	CcSEcCtD
Procainamide—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00038	0.00177	CcSEcCtD
Procainamide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000378	0.00176	CcSEcCtD
Procainamide—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000377	0.00176	CcSEcCtD
Procainamide—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000377	0.00176	CcSEcCtD
Procainamide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000374	0.00174	CcSEcCtD
Procainamide—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000373	0.00174	CcSEcCtD
Procainamide—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00173	CcSEcCtD
Procainamide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000371	0.00173	CcSEcCtD
Procainamide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00037	0.00172	CcSEcCtD
Procainamide—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.00172	CcSEcCtD
Procainamide—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000368	0.00172	CcSEcCtD
Procainamide—BCHE—nervous system—acquired immunodeficiency syndrome	0.000368	0.00365	CbGeAlD
Procainamide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000368	0.00171	CcSEcCtD
Procainamide—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000366	0.0017	CcSEcCtD
Procainamide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000366	0.0017	CcSEcCtD
Procainamide—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.0017	CcSEcCtD
Procainamide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000365	0.0017	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000364	0.0017	CcSEcCtD
Procainamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000363	0.00169	CcSEcCtD
Procainamide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000362	0.00169	CcSEcCtD
Procainamide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00036	0.00168	CcSEcCtD
Procainamide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000359	0.00167	CcSEcCtD
Procainamide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000356	0.00166	CcSEcCtD
Procainamide—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00166	CcSEcCtD
Procainamide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000356	0.00166	CcSEcCtD
Procainamide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000355	0.00165	CcSEcCtD
Procainamide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000355	0.00165	CcSEcCtD
Procainamide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000354	0.00165	CcSEcCtD
Procainamide—BCHE—central nervous system—acquired immunodeficiency syndrome	0.000354	0.00352	CbGeAlD
Procainamide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000354	0.00165	CcSEcCtD
Procainamide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000352	0.00164	CcSEcCtD
Procainamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000351	0.00164	CcSEcCtD
Procainamide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000351	0.00163	CcSEcCtD
Procainamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00035	0.00163	CcSEcCtD
Procainamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00035	0.00163	CcSEcCtD
Procainamide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000349	0.00163	CcSEcCtD
Procainamide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.00162	CcSEcCtD
Procainamide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.00162	CcSEcCtD
Procainamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000348	0.00162	CcSEcCtD
Procainamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000345	0.00161	CcSEcCtD
Procainamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000345	0.00161	CcSEcCtD
Procainamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.00161	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000344	0.0016	CcSEcCtD
Procainamide—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000344	0.0016	CcSEcCtD
Procainamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000342	0.00159	CcSEcCtD
Procainamide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000342	0.00159	CcSEcCtD
Procainamide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00034	0.00158	CcSEcCtD
Procainamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00034	0.00158	CcSEcCtD
Procainamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00034	0.00158	CcSEcCtD
Procainamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000339	0.00158	CcSEcCtD
Procainamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000339	0.00158	CcSEcCtD
Procainamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000339	0.00158	CcSEcCtD
Procainamide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000338	0.00157	CcSEcCtD
Procainamide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.00157	CcSEcCtD
Procainamide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000336	0.00156	CcSEcCtD
Procainamide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000336	0.00156	CcSEcCtD
Procainamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000333	0.00155	CcSEcCtD
Procainamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.00155	CcSEcCtD
Procainamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00033	0.00154	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000329	0.00153	CcSEcCtD
Procainamide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.00153	CcSEcCtD
Procainamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.00153	CcSEcCtD
Procainamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000328	0.00153	CcSEcCtD
Procainamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00153	CcSEcCtD
Procainamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000327	0.00152	CcSEcCtD
Procainamide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000327	0.00152	CcSEcCtD
Procainamide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.00152	CcSEcCtD
Procainamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000326	0.00152	CcSEcCtD
Procainamide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000324	0.00151	CcSEcCtD
Procainamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000322	0.0015	CcSEcCtD
Procainamide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00032	0.00149	CcSEcCtD
Procainamide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00032	0.00149	CcSEcCtD
Procainamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.00148	CcSEcCtD
Procainamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000318	0.00148	CcSEcCtD
Procainamide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.00148	CcSEcCtD
Procainamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000316	0.00147	CcSEcCtD
Procainamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000316	0.00147	CcSEcCtD
Procainamide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000316	0.00147	CcSEcCtD
Procainamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000316	0.00147	CcSEcCtD
Procainamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000315	0.00147	CcSEcCtD
Procainamide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000315	0.00313	CbGeAlD
Procainamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000315	0.00147	CcSEcCtD
Procainamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00146	CcSEcCtD
Procainamide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00146	CcSEcCtD
Procainamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000311	0.00145	CcSEcCtD
Procainamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00031	0.00144	CcSEcCtD
Procainamide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.00144	CcSEcCtD
Procainamide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000309	0.00144	CcSEcCtD
Procainamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.00144	CcSEcCtD
Procainamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000307	0.00143	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.00142	CcSEcCtD
Procainamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000304	0.00142	CcSEcCtD
Procainamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000304	0.00142	CcSEcCtD
Procainamide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00141	CcSEcCtD
Procainamide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.0014	CcSEcCtD
Procainamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000301	0.0014	CcSEcCtD
Procainamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.0014	CcSEcCtD
Procainamide—CYP2D6—blood—acquired immunodeficiency syndrome	0.0003	0.00298	CbGeAlD
Procainamide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000299	0.00139	CcSEcCtD
Procainamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000299	0.00139	CcSEcCtD
Procainamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000298	0.00139	CcSEcCtD
Procainamide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000296	0.00138	CcSEcCtD
Procainamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000295	0.00137	CcSEcCtD
Procainamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000295	0.00137	CcSEcCtD
Procainamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000294	0.00137	CcSEcCtD
Procainamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000294	0.00137	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.00137	CcSEcCtD
Procainamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.00136	CcSEcCtD
Procainamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.00135	CcSEcCtD
Procainamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00029	0.00135	CcSEcCtD
Procainamide—SLC22A5—brain—acquired immunodeficiency syndrome	0.000289	0.00287	CbGeAlD
Procainamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00134	CcSEcCtD
Procainamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000287	0.00134	CcSEcCtD
Procainamide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00134	CcSEcCtD
Procainamide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000286	0.00133	CcSEcCtD
Procainamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000286	0.00133	CcSEcCtD
Procainamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000284	0.00132	CcSEcCtD
Procainamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000283	0.00132	CcSEcCtD
Procainamide—BCHE—brain—acquired immunodeficiency syndrome	0.000281	0.00279	CbGeAlD
Procainamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.0013	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.0013	CcSEcCtD
Procainamide—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000279	0.00277	CbGeAlD
Procainamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000278	0.0013	CcSEcCtD
Procainamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000276	0.00128	CcSEcCtD
Procainamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000274	0.00127	CcSEcCtD
Procainamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000273	0.00127	CcSEcCtD
Procainamide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.00127	CcSEcCtD
Procainamide—BCHE—lymph node—acquired immunodeficiency syndrome	0.000272	0.0027	CbGeAlD
Procainamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.00126	CcSEcCtD
Procainamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000267	0.00125	CcSEcCtD
Procainamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00124	CcSEcCtD
Procainamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.00124	CcSEcCtD
Procainamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00124	CcSEcCtD
Procainamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.00124	CcSEcCtD
Procainamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000264	0.00123	CcSEcCtD
Procainamide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.00123	CcSEcCtD
Procainamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.00123	CcSEcCtD
Procainamide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.00123	CcSEcCtD
Procainamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00121	CcSEcCtD
Procainamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.0012	CcSEcCtD
Procainamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000256	0.00119	CcSEcCtD
Procainamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00119	CcSEcCtD
Procainamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000255	0.00119	CcSEcCtD
Procainamide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00119	CcSEcCtD
Procainamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00119	CcSEcCtD
Procainamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000254	0.00118	CcSEcCtD
Procainamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.00118	CcSEcCtD
Procainamide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.00117	CcSEcCtD
Procainamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.00116	CcSEcCtD
Procainamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.00115	CcSEcCtD
Procainamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.00115	CcSEcCtD
Procainamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.00114	CcSEcCtD
Procainamide—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000244	0.00242	CbGeAlD
Procainamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00113	CcSEcCtD
Procainamide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00113	CcSEcCtD
Procainamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.00112	CcSEcCtD
Procainamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00112	CcSEcCtD
Procainamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.00111	CcSEcCtD
Procainamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Procainamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.0011	CcSEcCtD
Procainamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.0011	CcSEcCtD
Procainamide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000235	0.00233	CbGeAlD
Procainamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00108	CcSEcCtD
Procainamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00107	CcSEcCtD
Procainamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00107	CcSEcCtD
Procainamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.00106	CcSEcCtD
Procainamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00105	CcSEcCtD
Procainamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.00105	CcSEcCtD
Procainamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00103	CcSEcCtD
Procainamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00103	CcSEcCtD
Procainamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00103	CcSEcCtD
Procainamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.00101	CcSEcCtD
Procainamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.001	CcSEcCtD
Procainamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000991	CcSEcCtD
Procainamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00099	CcSEcCtD
Procainamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000979	CcSEcCtD
Procainamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000953	CcSEcCtD
Procainamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000946	CcSEcCtD
Procainamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000925	CcSEcCtD
Procainamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000909	CcSEcCtD
Procainamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000891	CcSEcCtD
Procainamide—CYP2D6—brain—acquired immunodeficiency syndrome	0.000186	0.00185	CbGeAlD
Procainamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00085	CcSEcCtD
